- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 29.59M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $866.65K |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $824.25K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $5.42M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $5.43M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 29.66M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 29.66M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $7.43K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$98.91K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $2.7M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $2.77M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $2.85M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $1.24K |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $2.39K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$68.33K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$156.64K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$88.31K |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$45.84K |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$215.13K |